Compare Bundamedik Tbk (BMHS) vs Niramas Utama Tbk. (JELI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Niramas Utama Tbk. — how do they compare? Bundamedik Tbk trades at Rp188 (market cap 1.63T, 725.9K 24h volume), while Niramas Utama Tbk. trades at Rp635 (market cap 848.22B, 10.75M 24h volume). The key difference: Bundamedik Tbk is the larger of the two by market cap, and Niramas Utama Tbk. is more actively traded (10.75M versus 725.9K). Which is the better fit depends on your goals.
| BMHS | JELI | |
|---|---|---|
Market Cap | 1.63T | 848.22B |
Volume | 725.9K | 10.75M |
Lot | 7.26K | 107.48K |
Turnover | 135.94M | 6.9B |
Average Price | 187.26 | 642.24 |
Value | 135.94M | 6.9B |
Indicative Equilibrium Price | 188 | 635 |
Indicative Equilibrium Volume | 1 | 6.4K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Niramas Utama Tbk.
PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Read more on JELI →
